Sanofi’s Bozidar Jovicevic on how the company is approaching...

Paul Tunnah caught up with Sanofi’s vice president, global head of digital therapeutics at JP Morgan to talk about the landscape for digital health and the company’s plans for the space, in

Sanofi to combat shortages with European medicines ingredien...

Sanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – the essential building blocks of medicines that are causing concerns

Sanofi Pasteur to develop COVID-19 vaccine with US governmen...

Sanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a US government department to develop a novel COVID-19 coronavirus vaccine.

CMO Nathwani out as Sanofi's Hudson slims top executive team

Sanofi's Dupixent funded in Wales and Scotland for adolescen...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis.

Lilly swoops on Dermira to claim Dupixent rival